ReviewInternational journal of ophthalmology2025
Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population.
Review in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and safety of ultrasound cycloplasty as the first treatment in glaucoma for eyes with functional vision: A 1-year prospective study.Advances in ophthalmology practice and researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a non-invasive surgical procedure ultrasound cyclo-plasty (UCP) has gained attention among ophthalmologists in recent years. Derived from the application of high-intensity focused ultrasound, it has been utilized for the treatment of various types of glaucoma, demonstrating notable efficacy and safety. This review focuses on the efficacy and safety of UCP in treating glaucoma among Asian populations. By summarizing and analyzing existing literature on indications, therapeutic outcomes, and safety profiles, this review further highlights the unique advantages of UCP in glaucoma treatment compared to traditional surgical approaches. These advantages include broader indications, non-invasive nature, quantifiable treatment, excellent intraocular pressure-lowering effects, fewer adverse reactions, and high safety. Additionally, by introducing the underlying mechanism of action, this review explores the factors influencing its therapeutic efficacy, providing theoretical insights for clinical practice and demonstrating UCP's potential in glaucoma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.